TROW vs VIR · P/E 12, rev $7.09B vs rev $74.2M
T. Rowe Price Group Inc (TROW) versus Vir Biotechnology Inc (VIR) — a side-by-side from cached financials, not a winner call.
T. Rowe Price Group Inc (TROW) is a asset management company listed on NASDAQ.
Vir Biotechnology Inc (VIR) is a biotechnology company listed on NASDAQ.
Latest reported TROW revenue for 2024-12-31 was $7.09B. Net income was $2.14B. Revenue was up 9.8% from 2023-12-31 to 2024-12-31. TROW currently screens at market cap $23.17B and trailing P/E 11.6.
Latest reported VIR revenue for 2024-12-31 was $74.2M. Net income was -$522.0M. Revenue was down 13.9% from 2023-12-31 to 2024-12-31. VIR currently screens at market cap $1.45B.
TROW currently screens at market cap $23.17B and trailing P/E 11.6. VIR currently screens at market cap $1.45B.
Not investment advice. Open the TROW and VIR stock pages for the full models.
Not investment advice.